Allergic Bronchopulmonary Aspergillosis in Asthma: Epidemiological, Clinical and Therapeutic Issues

• Agarwal R , ChakrabartiA. Epidemiology of allergic bronchopulmonary aspergillosis. In:Aspergillosis: From Diagnosis to Prevention, PasqualottoAC (Ed.). Springer, NY, USA, 671–688 (2010).
   Google Scholar
• Agarwal R . Allergic Bronchopulmonary Aspergillosis. In:Textbook of Pulmonary and Critical Care Medicine.JindalSK, ShankarPS, RaoofS, GuptaD, AggarwalAN, AgarwalR (Eds). Jaypee Publications, New Delhi, India, 947–970 (2010).
   Google Scholar
• Agarwal R . Allergic bronchopulmonary aspergillosis.Chest135(3), 805–826 (2009).
   PubMed Web of Science ®Google Scholar
• Hinson KF , MoonAJ, PlummerNS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases.Thorax7(4), 317–333 (1952).
   PubMed Web of Science ®Google Scholar
• Imbeau SA , CohenM, ReedCE. Allergic bronchopulmonary aspergillosis in infants.Am. J. Dis. Child.131(10), 1127–1130 (1977).
   PubMedGoogle Scholar
• Kirsten D , NowakD, RabeKF, MagnussenH. [Diagnosis of bronchopulmonary aspergillosis is often made too late].Med. Klin. (Munich)88(6), 353–356 (1993).
   PubMedGoogle Scholar
• Agarwal R , ChakrabartiA. Clinical manifestations and natural history of allergic bronchopulmonary aspergillosis. In:Aspergillosis: From Diagnosis to Prevention, PasqualottoAC (Ed.). Springer, NY, USA, 707–724 (2010).
   Google Scholar
• Al-Mobeireek AF , El-RabM, Al-HedaithySS, AlasaliK, Al-MajedS, JoharjyI. Allergic bronchopulmonary mycosis in patients with asthma: period prevalence at a university hospital in Saudi Arabia.Respir. Med.95(5), 341–347 (2001).
   PubMed Web of Science ®Google Scholar
• Chakrabarti A , SethiS, RamanDS, BeheraD. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital.Mycoses45(8), 295–299 (2002).
   PubMed Web of Science ®Google Scholar
• Agarwal R , GuptaD, AggarwalAN, BeheraD, JindalSK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India.Chest130(2), 442–448 (2006).
   PubMed Web of Science ®Google Scholar
• Agarwal R , GuptaD, AggarwalAN, SaxenaAK, ChakrabartiA, JindalSK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients.Chest132(4), 1183–1190 (2007).
   PubMed Web of Science ®Google Scholar
• Agarwal R , ChakarbartiA, ShahAet al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin. Exp. Allergy 43(8), 850–873 (2013).
   PubMed Web of Science ®Google Scholar
• Agarwal R , GuptaD. Severe asthma and fungi: current evidence.Med. Mycol.49(Suppl. 1), S150–S157 (2011).
   PubMed Web of Science ®Google Scholar
• Denning DW , O‘DriscollBR, HogaboamCM, BowyerP, NivenRM. The link between fungi and severe asthma: a summary of the evidence.Eur. Respir. J.27(3), 615–626 (2006).
   PubMed Web of Science ®Google Scholar
• Agarwal R . Severe asthma with fungal sensitization.Curr. Allergy Asthma Rep.11(5), 403–413 (2011).
   PubMed Web of Science ®Google Scholar
• Denning DW , O‘DriscollBR, PowellGet al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am. J. Respir. Crit. Care Med. 179(1), 11–18 (2009).
   PubMed Web of Science ®Google Scholar
• Agarwal R . Allergic bronchopulmonary aspergillosis: lessons learnt from genetics.Indian J. Chest Dis. Allied Sci.53(3), 137–140 (2011).
   PubMedGoogle Scholar
• Kramer MN , KurupVP, FinkJN. Allergic bronchopulmonary aspergillosis from a contaminated dump site.Am. Rev. Respir. Dis.140(4), 1086–1088 (1989).
   PubMedGoogle Scholar
• Coughlan CA , ChotirmallSH, RenwickJet al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am. J. Respir. Crit. Care Med. 186(10), 999–1007 (2012).
   PubMed Web of Science ®Google Scholar
• Agarwal R , GargM, AggarwalAN, SaikiaB, GuptaD, ChakrabartiA. Serologic allergic bronchopulmonary aspergillosis (ABPA‑S): long-term outcomes.Respir. Med.106(7), 942–947 (2012).
   PubMed Web of Science ®Google Scholar
• Chowdhary A , AgarwalK, KathuriaS, GaurSN, RandhawaHS, MeisJF. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview.Crit. Rev. Microbiol. doi:10.3109/1040841X.754401 (2013) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Gergen PJ , ArbesSJJr,CalatroniA,MitchellHE,ZeldinDC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005–2006.J. Allergy Clin. Immunol.124(3), 447–453 (2009).
   PubMed Web of Science ®Google Scholar
• Agarwal R , AggarwalAN, GuptaD, JindalSK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis.Int. J. Tuberc. Lung Dis.13(8), 936–944 (2009).
   PubMed Web of Science ®Google Scholar
• Benatar SR , KeenGA,DuToit Naude W. Aspergillus hypersensitivity in asthmatics in Cape Town.Clin. Allergy10(3), 285–291 (1980).
   PubMedGoogle Scholar
• Donnelly SC , MclaughlinH, BredinCP. Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985–1988.Ir. J. Med. Sci.160(9), 288–290 (1991).
   PubMed Web of Science ®Google Scholar
• Novey HS . Epidemiology of allergic bronchopulmonary aspergillosis.Immunol. Allergy Clin. North Am.18(3), 641–653 (1998).
   Web of Science ®Google Scholar
• Eaton T , GarrettJ, MilneD, FrankelA, WellsAU. Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm.Chest118(1), 66–72 (2000).
   PubMed Web of Science ®Google Scholar
• Ma YL , ZhangWB, YuB, ChenYW, MuS, CuiYL. [Prevalence of allergic bronchopulmonary aspergillosis in Chinese patients with bronchial asthma].Zhonghua Jie He He Hu Xi Za Zhi34(12), 909–913 (2011).
   PubMedGoogle Scholar
• Agarwal R , NathA, AggarwalAN, GuptaD, ChakrabartiA. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in north India.Mycoses53(2), 138–143 (2010).
   PubMed Web of Science ®Google Scholar
• Denning DW , PleuvryA, ColeDC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults.Med. Mycol.51(4), 361–370 (2013).
   PubMed Web of Science ®Google Scholar
• Chakrabarti A , AgarwalR, ColeDC, PleuvryA, DenningDW. Estimation of the burden of chronic and allergic aspergillosis in India.Presented at: ESCMID-ECCMID.Berlin, Germany, 27–30April2013 ( Poster 1045).
   Google Scholar
• Agarwal R , MaskeyD, AggarwalANet al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS ONE 8(4), e61105 (2013).
   PubMed Web of Science ®Google Scholar
• Bousquet J , AntoJM, BachertCet al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy 61(6), 671–680 (2006).
   PubMed Web of Science ®Google Scholar
• Patterson R , FinkJN, PruzanskyJJet al. Serum immunoglobulin levels in pulmonary allergic aspergillosis and certain other lung diseases, with special reference to immunoglobulin E. Am. J. Med. 54(1), 16–22 (1973).
   PubMed Web of Science ®Google Scholar
• Wang JL , PattersonR, RosenbergM, RobertsM, CooperBJ. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis.Am. Rev. Respir. Dis.117(5), 917–927 (1978).
   PubMed Web of Science ®Google Scholar
• Baxter CG , DunnG, JonesAMet al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J. Allergy Clin. Immunol. 132(3), 560–566 (2013).
   PubMed Web of Science ®Google Scholar
• Marchant JL , WarnerJO, BushA. Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis.Thorax49(10), 1002–1005 (1994).
   PubMed Web of Science ®Google Scholar
• Ricketti AJ , GreenbergerPA, PattersonR. Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis.J. Allergy Clin. Immunol.74(1), 68–71 (1984).
   PubMed Web of Science ®Google Scholar
• Agarwal R , GuptaD, AggarwalANet al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir. Med. 104(2), 204–210 (2010).
   PubMed Web of Science ®Google Scholar
• Campbell MJ , ClaytonYM. Bronchopulmonary aspergillosis. A correlation of the clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis.Am. Rev. Respir. Dis.89, 186–196 (1964).
   PubMed Web of Science ®Google Scholar
• McCarthy DS , PepysS. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 1. Clinical features.Clin. Allergy1(1), 261–286 (1971).
   Google Scholar
• McCarthy DS , PepysJ. Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests.Clin. Allergy1(4), 415–432 (1971).
   PubMedGoogle Scholar
• Longbottom JL , PepysJ. Pulmonary aspergillosis: diagnostic and immunological significance of antigens and C-substance in Aspergillus Fumigatus.J. Pathol. Bacteriol.88, 141–151 (1964).
   PubMedGoogle Scholar
• Baxter CG , DenningDW, JonesAM, ToddA, MooreCB, RichardsonMD. Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis.Clin. Microbiol. Infect.19(4), e197–e204 (2013).
   PubMed Web of Science ®Google Scholar
• Agarwal R , KhanA, AggarwalANet al. Clinical relevance of peripheral blood eosinophil count in allergic bronchopulmonary aspergillosis. J. Infect. Public Health 4(5–6), 235–243 (2011).
   PubMedGoogle Scholar
• Agarwal R , NoelV, AggarwalAN, GuptaD, ChakrabartiA. Clinical significance of Aspergillus sensitisation in bronchial asthma.Mycoses54(5), e531–e538 (2011).
   PubMed Web of Science ®Google Scholar
• Pashley CH , FairsA, MorleyJPet al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med. Mycol. 50(4), 433–438 (2012).
   PubMed Web of Science ®Google Scholar
• Denning DW , ParkS, Lass-FlorlCet al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52(9), 1123–1129 (2011).
   PubMed Web of Science ®Google Scholar
• Kurup VP , BanerjeeB, HemmannS, GreenbergerPA, BlaserK, CrameriR. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA.Clin. Exp. Allergy30(7), 988–993 (2000).
   PubMed Web of Science ®Google Scholar
• Crameri R , HemmannS, IsmailC, MenzG, BlaserK. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis.Int. Immunol.10(8), 1211–1216 (1998).
   PubMed Web of Science ®Google Scholar
• Crameri R . Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications.Int. Arch. Allergy Immunol.115(2), 99–114 (1998).
   PubMed Web of Science ®Google Scholar
• Crameri R , LidholmJ, GronlundH, StuberD, BlaserK, MenzG. Automated specific IgE assay with recombinant allergens: evaluation of the recombinant Aspergillus fumigatus allergen I in the Pharmacia Cap System.Clin. Exp. Allergy26(12), 1411–1419 (1996).
   PubMed Web of Science ®Google Scholar
• Bowyer P , BlightmanO, DenningDW. Relative reactivity of Aspergillus allergens used in serological tests.Med. Mycol.44(Suppl. 1), 23–28 (2006).
   PubMed Web of Science ®Google Scholar
• Agarwal R , KhanA, GargM, AggarwalAN, GuptaD. Pictorial essay: allergic bronchopulmonary aspergillosis.Indian J. Radiol. Imaging21(4), 242–252 (2011).
   PubMedGoogle Scholar
• Lynch DA . Imaging of asthma and allergic bronchopulmonary mycosis.Radiol. Clin. North Am.36(1), 129–142 (1998).
   PubMed Web of Science ®Google Scholar
• Panchal N , BhagatR, PantC, ShahA. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances.Respir. Med.91(4), 213–219 (1997).
   PubMed Web of Science ®Google Scholar
• Hansell DM , StricklandB. High-resolution computed tomography in pulmonary cystic fibrosis.Br. J. Radiol.62(733), 1–5 (1989).
   PubMed Web of Science ®Google Scholar
• Agarwal R , KhanA, GargM, AggarwalAN, GuptaD. Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis.World J. Radiol.4(4), 141–150 (2012).
   PubMedGoogle Scholar
• Reiff DB , WellsAU, CarrDH, ColePJ, HansellDM. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types.AJR Am. J. Roentgenol.165(2), 261–267 (1995).
   PubMed Web of Science ®Google Scholar
• Agarwal R . High attenuation mucoid impaction in allergic bronchopulmonary aspergillosis.World J. Radiol.2(1), 41–43 (2010).
   PubMedGoogle Scholar
• Goyal R , WhiteCS, TempletonPA, BrittEJ, RubinLJ. High attenuation mucous plugs in allergic bronchopulmonary aspergillosis: CT appearance.J. Comput. Assist. Tomogr.16(4), 649–650 (1992).
   PubMed Web of Science ®Google Scholar
• Logan PM , MullerNL. High-attenuation mucous plugging in allergic bronchopulmonary aspergillosis.Can. Assoc. Radiol. J.47(5), 374–377 (1996).
   PubMed Web of Science ®Google Scholar
• Agarwal R , AggarwalAN, GuptaD. High-attenuation mucus in allergic bronchopulmonary aspergillosis: another cause of diffuse high-attenuation pulmonary abnormality.AJR Am. J. Roentgenol.186(3), 904 (2006).
   PubMed Web of Science ®Google Scholar
• Smith NL , DenningDW. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma.Eur. Respir. J.37(4), 865–872 (2011).
   PubMed Web of Science ®Google Scholar
• Rosenberg M , PattersonR, MintzerR, CooperBJ, RobertsM, HarrisKE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis.Ann. Intern. Med.86(4), 405–414 (1977).
   PubMed Web of Science ®Google Scholar
• Patterson R , GreenbergerPA, HalwigJM, LiottaJL, RobertsM. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies.Arch. Intern. Med.146(5), 916–918 (1986).
   PubMedGoogle Scholar
• Agarwal R . Controversies in allergic bronchopulmonary aspergillosis.Int. J. Respir. Care6(2), 53–54, 56–63 (2010).
   Google Scholar
• Agarwal R , HazarikaB, GuptaD, AggarwalAN, ChakrabartiA, JindalSK. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA?Med. Mycol.48(7), 988–994 (2010).
   PubMed Web of Science ®Google Scholar
• Patterson R , GreenbergerPA, RadinRC, RobertsM. Allergic bronchopulmonary aspergillosis: staging as an aid to management.Ann. Intern. Med.96(3), 286–291 (1982).
   PubMed Web of Science ®Google Scholar
• Agarwal R , KhanA, GuptaD, AggarwalAN, SaxenaAK, ChakrabartiA. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus.PLoS ONE5(12), e15346 (2010).
   PubMed Web of Science ®Google Scholar
• Agarwal R , AggarwalAN, GargM, SaikiaB, GuptaD, ChakrabartiA. Allergic bronchopulmonary aspergillosis with aspergilloma: an immunologically severe disease with poor outcome.Mycopathologia174(3), 193–201 (2012).
   PubMed Web of Science ®Google Scholar
• Halwig JM , GreenbergerPA, LevineM, PattersonR. Recurrence of allergic bronchopulmonary aspergillosis after seven years of remission.J. Allergy Clin. Immunol.74(5), 738–740 (1984).
   PubMed Web of Science ®Google Scholar
• Lee TM , GreenbergerPA, PattersonR, RobertsM, LiottaJL. Stage V (fibrotic) allergic bronchopulmonary aspergillosis. A review of 17 cases followed from diagnosis.Arch. Intern. Med.147(2), 319–323 (1987).
   PubMedGoogle Scholar
• Baur X , WeissW, JaroschBet al. Immunoprint pattern in patients with allergic bronchopulmonary aspergillosis in different stages. J. Allergy Clin. Immunol. 83(4), 839–844 (1989).
   PubMed Web of Science ®Google Scholar
• Greenberger PA , MillerTP, RobertsM, SmithLL. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis.Ann. Allergy70(4), 333–338 (1993).
   PubMedGoogle Scholar
• Kumar R . Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation.Chest124(3), 890–892 (2003).
   PubMed Web of Science ®Google Scholar
• Agarwal R . What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.Expert Rev. Respir. Med.6(4), 363–371 (2012).
   PubMed Web of Science ®Google Scholar
• Frauman AG . An overview of the adverse reactions to adrenal corticosteroids.Adverse Drug React. Toxicol. Rev.15(4), 203–206 (1996).
   PubMedGoogle Scholar
• Schacke H , DockeWD, AsadullahK. Mechanisms involved in the side effects of glucocorticoids.Pharmacol. Ther.96(1), 23–43 (2002).
   PubMed Web of Science ®Google Scholar
• Denning DW , VanWye JE, LewistonNJ, StevensDA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.Chest100(3), 813–819 (1991).
   PubMed Web of Science ®Google Scholar
• Stevens DA , SchwartzHJ, LeeJYet al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N. Engl. J. Med. 342(11), 756–762 (2000).
   PubMed Web of Science ®Google Scholar
• Wark PA , HensleyMJ, SaltosNet al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J. Allergy Clin. Immunol. 111(5), 952–957 (2003).
   PubMed Web of Science ®Google Scholar
• Nepomuceno IB , EsrigS, MossRB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole.Chest115(2), 364–370 (1999).
   PubMed Web of Science ®Google Scholar
• Hilton AM , ChatterjeeSS. Bronchopulmonary aspergillosis – treatment with beclomethasone dipropionate.Postgrad. Med. J.51(Suppl. 4), 98–103 (1975).
   PubMed Web of Science ®Google Scholar
• Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Report to the Research Committee of the British Thoracic Association. Br. J. Dis. Chest 73(4), 349–356 (1979).
   PubMedGoogle Scholar
• Heinig JH , WeekeER, GrothS, SchwartzB. High-dose local steroid treatment in bronchopulmonary aspergillosis. A pilot study.Allergy43(1), 24–31 (1988).
   PubMed Web of Science ®Google Scholar
• Balter MS , RebuckAS. Treatment of allergic bronchopulmonary aspergillosis with inhaled corticosteroids.Respir. Med.86(5), 441–442 (1992).
   PubMed Web of Science ®Google Scholar
• Imbeault B , CormierY. Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis.Chest103(5), 1614–1617 (1993).
   PubMed Web of Science ®Google Scholar
• Seaton A , SeatonRA, WightmanAJ. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow-up.QJM87(9), 529–537 (1994).
   PubMed Web of Science ®Google Scholar
• Agarwal R , KhanA, AggarwalAN, SaikiaB, GuptaD, ChakrabartiA. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA).Intern. Med.50(8), 855–860 (2011).
   PubMed Web of Science ®Google Scholar
• Laoudi Y ,PaoliniJB,GrimfedA,JustJ. Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?Eur. Respir. J.31(4), 908–909 (2008).
   PubMed Web of Science ®Google Scholar
• Hayes D Jr ,MurphyBS,LynchJE,FeolaDJ. Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis.Pediatr. Pulmonol.45(11), 1145–1148 (2010).
   PubMed Web of Science ®Google Scholar
• Proesmans M , VermeulenF, VreysM,DeBoeck K. Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.Int. J. Pediatr.2010, 376287 (2010).
   PubMedGoogle Scholar
• Godet C , MeuriceJC, RoblotFet al. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. Eur. Respir. J. 39(5), 1261–1263 (2012).
   PubMed Web of Science ®Google Scholar
• van der Ent CK , HoekstraH, RijkersGT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody.Thorax62(3), 276–277 (2007).
   PubMed Web of Science ®Google Scholar
• Zirbes JM , MillaCE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis.Pediatr. Pulmonol.43(6), 607–610 (2008).
   PubMed Web of Science ®Google Scholar
• Alcorta A . Successful treatment of allergic bronchopulmonary aspergillosis with omalizumab.Allergy64, 477–478 (2009).
   Web of Science ®Google Scholar
• Brinkmann F , SchwerkN, HansenG, BallmannM. Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis.Allergy65(1), 134–135 (2010).
   PubMed Web of Science ®Google Scholar
• Perez-De-Llano LA , VenneraMC, ParraAet al. Effects of omalizumab in Aspergillus-associated airway disease. Thorax 66(6), 539–540 (2011).
   PubMed Web of Science ®Google Scholar
• Tillie-Leblond I , GermaudP, LeroyerCet al. Allergic bronchopulmonary aspergillosis and omalizumab. Allergy 66(9), 1254–1256 (2011).
   PubMed Web of Science ®Google Scholar
• Sastre I , BlancoJ, MataH, GarciaF. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.J. Investig. Allergol. Clin. Immunol.22(2), 145–147 (2012).
   PubMed Web of Science ®Google Scholar
• Wong R , WongM, RobinsonPD, FitzgeraldDA. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.Paediatr. Respir. Rev.14(1), 22–24 (2013).
   PubMed Web of Science ®Google Scholar
• Thomson JM , WesleyA, ByrnesCA, NixonGM. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis.Pediatr. Pulmonol.41(2), 164–170 (2006).
   PubMed Web of Science ®Google Scholar
• Cohen-Cymberknoh M , BlauH, ShoseyovDet al. Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis. J. Cyst. Fibros. 8(4), 253–257 (2009).
   PubMed Web of Science ®Google Scholar
• Sehgal IS , AgarwalR. Pulse methylprednisolone in ABPA exacerbations: case-report and review of literature.Eur. Respir. Rev. (2013) (In Press).
   Google Scholar
• Hilliard T , EdwardsS, BuchdahlRet al. Voriconazole therapy in children with cystic fibrosis. J. Cyst. Fibros. 4(4), 215–220 (2005).
   PubMedGoogle Scholar
• Mccallum BJ , AmrolD, HorvathJ, InayatN, TalwaniR. A case of allergic bronchopulmonary aspergillosis leading to pneumonia with unusual organisms.South. Med. J.98(11), 1135–1138 (2005).
   PubMed Web of Science ®Google Scholar
• Erwin GE , FitzgeraldJE. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.J. Asthma44(10), 891–895 (2007).
   PubMed Web of Science ®Google Scholar
• Glackin L , LeenG, ElnazirB, GreallyP. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.Ir. Med. J.102(1), 29 (2009).
   PubMedGoogle Scholar
• Chishimba L , NivenRM, CooleyJ, DenningDW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.J. Asthma49(4), 423–433 (2012).
   PubMed Web of Science ®Google Scholar
• Bolland MJ , BaggW, ThomasMG, LucasJA, TicehurstR, BlackPN. Cushing‘s syndrome due to interaction between inhaled corticosteroids and itraconazole.Ann. Pharmacother.38(1), 46–49 (2004).
   PubMed Web of Science ®Google Scholar
• De W achter E ,VanbesienJ,DeSchutter I,MalfrootA,DeSchepper J. Rapidly developing Cushing syndrome in a 4‑year-old patient during combined treatment with itraconazole and inhaled budesonide.Eur. J. Pediatr.162(7–8), 488–489 (2003).
   PubMed Web of Science ®Google Scholar
• Parmar JS , HowellT, KellyJ, BiltonD. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis.Thorax57(8), 749–750 (2002).
   PubMed Web of Science ®Google Scholar
• Naef R , SchmidC, HoferM, MinderS, SpeichR, BoehlerA. Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients.Respiration74(4), 418–422 (2007).
   PubMed Web of Science ®Google Scholar
• Gilchrist FJ , CoxKJ, RoweRet al. Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis. J. Cyst. Fibros. 12(4), 399–402 (2013).
   PubMed Web of Science ®Google Scholar
• Nair P , PizzichiniMM, KjarsgaardMet al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 360(10), 985–993 (2009).
   PubMed Web of Science ®Google Scholar
• Corren J , LemanskeRF, HananiaNAet al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 365(12), 1088–1098 (2011).
   PubMed Web of Science ®Google Scholar
• Greenberger PA . Allergic bronchopulmonary aspergillosis.J. Allergy Clin. Immunol.110(5), 685–692 (2002).
   PubMed Web of Science ®Google Scholar
• Vlahakis NE , AksamitTR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis.Mayo Clin. Proc.76(9), 930–938 (2001).
   PubMed Web of Science ®Google Scholar

Websites

• Trial on the efficacy and safety of two different glucocorticoid dose regimens in allergic bronchopulmonary aspergillosis. http://clinicaltrials.gov/show/NCT00974766
   Google Scholar
• Monotherapy of itraconazole versus prednisolone in allergic bronchopulmonary aspergillosis (MIPA). http://clinicaltrials.gov/show/NCT01321827
   Google Scholar